Heart failure & cardiomyopathies

Artificial Intelligence for Detection of Prognostically Significant Left Ventricular Dysfunction From Echocardiography

JACC AdvPublished development and testing of an artificial intelligence algorithm

Authors' conclusion

A new AI-LVD algorithm using only echocardiographic measurements can reliably identify prognostically important LV dysfunction, including in preserved EF, even when key reporting parameters are missing. The AI-LVD can be used in real-time during routine echocardiography reporting.

Study context

Population
Cases from the National Echo Database of Australia with no mitral valve intervention or pacemakertest cohort, 41,796 men (51.3%) and 39,713 women · imputation cohort 126,136 · training cohort 254,735 · test cohort 81,509
Participants
81,509 cases
Comparison
Highest vs lowest decile group
Outcome
Actual 5-year mortality across AI-LVD deciles
Follow-up
5-year

Main finding

As reported in the abstract

Men, lowest to highest decile

5.7% to 66.3%

Women, lowest to highest decile

2.3% to 64.2%

Further findings

OutcomeAdjusted hazard (95% CI)
All-cause mortality in preserved EF, adjusted for age, year of echo, and missing echo parameters · 1,541 (812-2,682) days follow-upHighest decile vs lowest decile · men4.93-fold (4.35–5.59)
All-cause mortality in preserved EF, adjusted for age, year of echo, and missing echo parameters · 1,541 (812-2,682) days follow-upHighest decile vs lowest decile · women7.11-fold (5.85–8.64)

Ejection fraction (EF) and filling pressure status in test cohort

Reduced EF
4,490 (5.5%)
Mildly reduced EF
3,734 (4.6%)
Preserved EF
59,297 (72.7%)
No recorded EF
13,988 (17.2%)
"indeterminate" filling pressures
39,940 (45.2%)

Original publication

Artificial Intelligence for Detection of Prognostically Significant Left Ventricular Dysfunction From Echocardiography. JACC Adv. Published 23 June 2025. doi:10.1016/j.jacadv.2025.101891

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.